Overview

Efficacy and Safety of LAS41003 in the Treatment of Intertriginous Candida Infections

Status:
Completed
Trial end date:
2011-07-01
Target enrollment:
Participant gender:
Summary
The aim of this study is to determine the efficacy and safety of once daily topical application of the combinational cream LAS41003 compared to the corresponding mono-substances in the treatment of candida infections in intertriginous areas at the trunk.
Phase:
Phase 2
Details
Lead Sponsor:
Almirall, S.A.